Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes.

Oechsler RA, Feilmeier MR, Miller D, Shi W, Hofling-Lima AL, Alfonso EC.

Cornea. 2013 May;32(5):667-73. doi: 10.1097/ICO.0b013e318277ac74.

2.

Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes.

Oechsler RA, Yamanaka TM, Bispo PJ, Sartori J, Yu MC, Melo AS, Miller D, Hofling-Lima AL.

Clin Ophthalmol. 2013;7:1693-701. doi: 10.2147/OPTH.S40063.

3.

Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.

Mukherjee PK, Chandra J, Yu C, Sun Y, Pearlman E, Ghannoum MA.

Invest Ophthalmol Vis Sci. 2012 Jul 3;53(8):4450-7. doi: 10.1167/iovs.12-9848.

4.

Benefit of polyhexamethylene biguanide in Fusarium keratitis.

Behrens-Baumann W, Seibold M, Hofmüller W, Walter S, Haeberle H, Wecke T, Tammer I, Tintelnot K.

Ophthalmic Res. 2012;48(4):171-6. doi: 10.1159/000337140.

PMID:
22710976
5.

Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.

Homa M, Shobana CS, Singh YR, Manikandan P, Selvam KP, Kredics L, Narendran V, Vágvölgyi C, Galgóczy L.

Mycoses. 2013 Sep;56(5):501-11. doi: 10.1111/myc.12062.

PMID:
23437826
7.

Keratitis due to Fusarium langsethiae: clinical profile, molecular identification, and susceptibility to antifungals.

Vasantha Ruban V, Geraldine P, Kaliamurthy J, Jesudasan CA, Thomas PA.

Mycopathologia. 2015 Jun;179(5-6):453-8. doi: 10.1007/s11046-015-9866-5.

PMID:
25645251
8.

European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.

Tortorano AM, Prigitano A, Esposto MC, Arsic Arsenijevic V, Kolarovic J, Ivanovic D, Paripovic L, Klingspor L, Nordøy I, Hamal P, Arikan Akdagli S, Ossi C, Grancini A, Cavanna C, Lo Cascio G, Scarparo C, Candoni A, Caira M, Drogari Apiranthitou M; ECMM Working Group..

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1623-30. doi: 10.1007/s10096-014-2111-1.

PMID:
24791951
9.
10.

Successful medical management of recalcitrant Fusarium solani keratitis: molecular identification and susceptibility patterns.

Taylan Sekeroglu H, Erdem E, Yagmur M, Gumral R, Ersoz R, Ilkit M, Harbiyeli II.

Mycopathologia. 2012 Sep;174(3):233-7. doi: 10.1007/s11046-012-9542-y.

PMID:
22528742
11.

Exogenous fungal endophthalmitis: microbiology and clinical outcomes.

Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC.

Ophthalmology. 2008 Sep;115(9):1501-7, 1507.e1-2. doi: 10.1016/j.ophtha.2008.02.027.

PMID:
18486220
12.

Utility of molecular sequence analysis of the ITS rRNA region for identification of Fusarium spp. from ocular sources.

Oechsler RA, Feilmeier MR, Ledee DR, Miller D, Diaz MR, Fini ME, Fell JW, Alfonso EC.

Invest Ophthalmol Vis Sci. 2009 May;50(5):2230-6. doi: 10.1167/iovs.08-2757.

PMID:
19136697
13.

Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.

Iqbal NJ, Boey A, Park BJ, Brandt ME.

Diagn Microbiol Infect Dis. 2008 Nov;62(3):348-50. doi: 10.1016/j.diagmicrobio.2008.07.003.

PMID:
18707841
14.

Pathogenic spectrum of fungal keratitis and specific identification of Fusarium solani.

He D, Hao J, Zhang B, Yang Y, Song W, Zhang Y, Yokoyama K, Wang L.

Invest Ophthalmol Vis Sci. 2011 Apr 25;52(5):2804-8. doi: 10.1167/iovs.10-5977.

PMID:
21273551
15.

[Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China].

Sun S, Lyu Q, Han L, Ma Q, Hu H, He S, Tao S, Zhang J, Zhang H, Wang L.

Zhonghua Yan Ke Za Zhi. 2015 Sep;51(9):660-7. Chinese.

PMID:
26693650
16.

In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.

Lalitha P, Sun CQ, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Cevallos V, McLeod SD, Acharya NR, Lietman TM; Mycotic Ulcer Treatment Trial Group..

Am J Ophthalmol. 2014 Feb;157(2):318-26. doi: 10.1016/j.ajo.2013.10.004.

17.

Clinicopathologic case reports of Alternaria and Fusarium keratitis in Canada.

Jiang K, Brownstein S, Baig K, Lam K, Toye B.

Can J Ophthalmol. 2013 Dec;48(6):e151-4. doi: 10.1016/j.jcjo.2013.07.008. No abstract available.

PMID:
24314429
18.

Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.

Sun CQ, Lalitha P, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM; Mycotic Ulcer Treatment Trial Group..

Ophthalmology. 2014 Aug;121(8):1495-500.e1. doi: 10.1016/j.ophtha.2014.03.004.

19.

Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases.

Pereira GH, de Angelis DA, Brasil RA, dos Anjos Martins M, de Matos Castro e Silva D, Szeszs MW, de Souza Carvalho Melhem M.

Mycopathologia. 2013 Feb;175(1-2):107-14. doi: 10.1007/s11046-012-9585-0.

PMID:
23076561
20.

Bilateral Fusarium oxysporum keratitis after laser in situ keratomileusis.

Labiris G, Troeber L, Gatzioufas Z, Stavridis E, Seitz B.

J Cataract Refract Surg. 2012 Nov;38(11):2040-4. doi: 10.1016/j.jcrs.2012.08.037.

PMID:
23079318
Items per page

Supplemental Content

Support Center